Hans Schikan
Director
pharmaceutical science
Gedeon Richter
Netherlands
Biography
From 2004 to 2013, Dutch total healthcare expenditures increased from EUR 42.5 billion [USD 47.8 billion] to EUR 68 billion (USD 75.6 billion]; 11.8% of Dutch GDP. These eye-wateringly unsustainable public-spending sprees placed the country as second only to the United States in terms of healthcare expenditure in relation to GDP, and above all its European counterparts including France, Switzerland and Germany.
Research Interest
Pharmacogenomics & Pharmacoproteomics
